Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Bulten wins major FSP contract for an electric vehicle program

Bulten has been awarded a new FSP (Full-Service Provider) contract by a European automotive manufacturer, which is also a new customer for Bulten. The contract relates to supply of fasteners for an electric vehicle program that is under development. The order value is approximately SEK 220 million a year at full production. Deliveries are estimated to start in the third quarter of 2022, reaching full pace by 2025.“We are proud to be appointed FSP provider of fasteners by a new customer, and for a new electric vehicle program. This is a strategically important contract for us since we are

Byggmax Group initiates a share buy-back program

The Board of Directors of Byggmax Group AB (“Byggmax” or the “Company”) has decided to exercise the authorization granted by the Annual General Meeting on May 6, 2021 and initiate repurchases of own shares. The maximum amount for which shares may be repurchased may not exceed SEK 200 million.Byggmax currently has a strong financial position. Despite investments in organic growth, add-on acquisitions and dividends to shareholders, cash flow from operations has further strengthened the company’s financial position, compared to the same period last year (second quarter). The introduction of a

ADDvise acquires Graham Medical Technologies, LLC

ADDvise Group AB has today entered into a share purchase agreement with the owner of Graham Medical Technologies, LLC (“GraMedica”) regarding the acquisition of all the outstanding shares of GraMedica in accordance with the letter of intent communicated via a press release dated 10[th] May 2021. Closing of the acquisition takes place today. GraMedica’s revenue for the year 2020 amounted to approximately USD 3.35 million, with an adjusted EBITDA of approximately USD 0.85 million, equaling an EBITDA-margin of 26%. The purchase price amounts to a total of approximately USD 5.8 million,

BICO has acquired HUREL micro liver technologies to offer the market's most comprehensive liver in vitro services

BICO, leading in Bio Convergence, has acquired the assets and operations of HUREL Corp. (HUREL), an American leading life sciences company focused on providing its customers with two-dimensional liver co-culture models and assay services. The acquired assets and operations of HUREL will be integrated into Visikol, a subsidiary in BICO.The addition of the HUREL liver co-culture models provides the market's most comprehensive liver in vitro model and assay offerings to meet the diverse requirements of its customers. BICO has acquired assets and operations of HUREL for a purchase price of

Genetic Analysis AS: Mandatory notification of trade

OSLO, NORWAY - 15 September 2021: Genetic Analysis AS (“GA” or “the Company”) announce that members of the Board and management have been allocated GEAN-shares and warrants of series TO 1 and TO 2 in connection with their IPO subscription.Kathryn M. Baker, Chairperson of the Board in Genetic Analysis AS, has through the fully owned company Lakeside AS today subscribed for and been allocated 64,100 GEAN-shares at a price of 7.80 NOK per share and in addition free of charge 38,460 subscription rights of series T0 1 and 44,870 subscription rights of series T0 2. Kathryn M. Baker including

Genetic Analysis AS: IPO prior to listing was significantly oversubscribed

OSLO, NORWAY - 15 September 2021: On 13 September 2021, the subscription period in Genetic Analysis AS (“GA” or “the Company”) issue of units (“the IPO”) prior to the planned listing on Spotlight Stock Market (“Spotlight”) ended. The IPO targeted NOK 60 million, of which NOK 48 million were pre-subscribed. Total subscriptions amounted to approximately NOK 99 million, corresponding to a subscription ratio of approximately 165 percent. An extraordinary general meeting on 20 September 2021 will formally decide on the IPO. The Company will thus receive approximately NOK 60 million before issue

Idogen continues to optimize its production method prior to the start of the patient study with IDO 8

Idogen AB announces today that it has initiated new activities in order to maximize the effect of the tolerogenic cell therapy IDO 8 before the start of the first clinical study. The company has already succeeded in establishing a patentable process for the GMP-production of individually tailored treatments. Åsa Schiött, CSO of Idogen: “Recently performed analyses show a potential to optimize the levels of the substance in cell therapy that the body should learn to recognize and tolerate. This in turn would increase the possibility of an improved treatment effect to benefit the patient”.

Tecnotree Corporation - Managers' transactions - Thomas

Person subject to the notification requirementName: Thomas, SajanPosition: Other senior managerIssuer: Tecnotree CorporationLEI: 743700MRPVYI7ASHCX38 Notification type: INITIAL NOTIFICATIONReference number: 743700MRPVYI7ASHCX38_20210909230139_249____________________________________________ Transaction date: 2021-09-14Venue not applicableInstrument type: SHAREISIN: FI0009010227Nature of the transaction: SUBSCRIPTION(X) Linked to stock option programme Transaction details(1): Volume: 50000 Unit price: 0.40 EUR Aggregated transactions(1): Volume: 50000

Tecnotree Corporation - Managers' transactions - Ketkar

Person subject to the notification requirementName: Ketkar, SanjayPosition: Other senior managerIssuer: Tecnotree CorporationLEI: 743700MRPVYI7ASHCX38 Notification type: INITIAL NOTIFICATIONReference number: 743700MRPVYI7ASHCX38_20210910230151_250____________________________________________ Transaction date: 2021-09-14Venue not applicableInstrument type: SHAREISIN: FI0009010227Nature of the transaction: SUBSCRIPTION(X) Linked to stock option programme Transaction details(1): Volume: 31250 Unit price: 0.40 EUR Aggregated transactions(1): Volume: 31250

Herantis Pharma Plc launches an accelerated book building process to raise a minimum of EUR 4 million through a private placement of new shares

Herantis Pharma PlcCompany release, inside information, 15 September 2021 at 6:39 p.m. Eastern European Summer Time THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Herantis Pharma Plc ("Herantis" or the "Company") hereby announces its intention to issue new shares (the "Placing Shares") in a private placement to institutional and other qualified

ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 15.09.2021

ALEXANDRIA PANKKIIRILIIKE OYJ NOTIFICATION 15.09.2021 at 18:30 EEST ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 15.09.2021 Date 15.09.2021Exchange transaction BuyShare class ALEXAmount 1971Average price/share 8.4875 EURHighest price/share 8.4900 EURLowest price/share 8.4800 EURTotal price 16,728.86 EUR The shares held by Alexandria Pankkiiriliike Oyj on 15.09.2021: ALEX 19,484   On behalf of Alexandria Pankkiiriliike Oyj  Skandinaviska Enskilda Banken AB (Publ)

Neptunia Invest AB (publ) announces a consent solicitation for its outstanding up to SEK 300m senior secured floating rate bonds due 2024 and a contemplated issue of up to SEK 200m of Subsequent Bond

Consent solicitationNot for release, publication or distribution in or into the United States or to any person located or resident in any other jurisdiction where it is unlawful to distribute this announcement. Neptunia Invest AB (publ) reg. no. 556986-5453 (the "Company") today announces that it is soliciting consent from the holders of the outstanding up to SEK 300,000,000 senior secured floating rate bonds due 2024 (ISIN SE0013888120) (the "Bonds") (the "Bondholders") to make certain amendments to the terms and conditions of the Bonds dated 2 July 2021 (the "Term and Conditions") (the

Ingka Investments announces New Zealand land investment as part of its commitment towards responsible forest management

Ingka Group today announces it has acquired 5,500 hectares/55 million square metres of land in New Zealand’s South Island, as part of its long-term commitment to responsible forest management. The land - the Group's first investment in New Zealand - will be used for a 30 plus year afforestation* scheme to plant new forests. This will create long-term employment in the region, support increased biodiversity in addition to removing CO2 from the atmosphere and storing it in high-quality forests and in the land. The investment will be managed by Ingka Investments, the investment arm of Ingka

Read original

SpectrumOne has closed acquisition of Observit AB

SpectrumOne AB has today closed the acquisition of Observit AB as announced on September 6, 2021.The preliminary purchase price was settled by SEK 22 million in cash and SEK 39 million in shares by the Board of Directors resolving on a directed share issue setting off a sales credit of the same amount in SpectrumOne at a subscription price amounting to SEK 1,8476 per new share. The subscription price was calculated by using the average price for the last 20 days of trade of SpectrumOne’s stock on Nasdaq First North Growth Market before today's date. Through the directed issue of shares in

#21-306 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-305 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-304 Changes to certain Derivatives at NGM

Derivative with ISIN: SE0011724806 from Issuer Skandinaviska Enskilda Banken AB have had its last day of trading changed to 2021-09-20.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a

Minesto's CEO Martin Edlund nominated for the industry award Vi Maris

Minesto's CEO Dr Martin Edlund has been nominated for the industry body Ocean Energy Europe's Vi Maris Award. Vi Maris ("Force of the Sea") recognises individuals who have made outstanding contributions to the development of the ocean energy sector. The winner will be announced at the annual OEE conference in December 2021.Martin Edlund is nominated for the award for having “relentlessly driven forward tidal kite technology across several countries, attracting significant private investment, industry partnerships and media attention in the process.” The Vi Maris Award is presented for

CTEK launches a revolutionary new battery charger and maintainer, with APTO[TM] technology

Introducing the CS ONE: super smart, super safe and super simple to use!   CTEK AB, a leading global brand in vehicle charging solutions, has today launched the CS ONE, a revolutionary and powerful new battery charger and maintainer with APTO[TM] (Adaptive Charging) technology. The CS ONE is the smartest battery charger that CTEK has ever made – cutting-edge APTO[TM] technology does all the thinking for you, no need to worry about battery type, size or even positive and negative clamps, so it’s also extremely safe and easy to use.The CS ONE is super smart, automatically delivering

Medius Appoints Jim Lucier as Chief Executive Officer to Lead the Business Through Next Stage of Growth

Chief Marketing Officer Kim Albrecht bolsters leadership teamSTOCKHOLM, Sept. 15, 2021 – Medius, a leading provider of spend management solutions, announces the appointment of Jim Lucier as its new Chief Executive Officer (CEO). Per Åkerberg, who has been the Chief Executive Officer since 2015, will join the Medius Board of Directors. Lucier brings a wealth of expertise to this role, having served in several senior leadership capacities, most recently as President of SAP Concur, the leading travel and expense solution. Prior to that, Lucier served as Chief Revenue Officer for North

Sustainable coffee grown in Finland – the land that drinks the most coffee per capita produces its first tasty cup with cellular agriculture

Press release 15 September, 2021 VTT Technical Research Centre of Finland has successfully produced coffee cells in a bioreactor through cellular agriculture. The innovation can help to make the production of coffee more sustainable. The first batches produced by VTT in a laboratory in Finland smell and taste like conventional coffee.With increasing demand and numerous sustainability challenges concerning traditional coffee agriculture, there is a pressing need for alternative ways of producing coffee. Due to the high demand of coffee, more acreage is required to produce enough coffee

Diamyd Medical acquires property with manufacturing facility in Umeå, Sweden

Diamyd Medical today announes the acquisition of the property in Umeå where prodution of the recombinant protein GAD65, the active component in the therapeutic diabetes vaccine Diamyd[®] is being established. The property is acquired for a purchase price of SEK 24.5 million and comprises approximately 20 000 square feet including the 10 000 square feet Diamyd Medical rents today, as well as 90 000 square feet of land area.“The manufacturing facility is a crucial investment for the future and the acquisition gives us further opportunities to scale up and expand our manufacturing activities”,

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release September 15, 2021 at 3:00 p.m. Nokian Tyres has received an announcement from BlackRock, Inc. on September 15, 2021, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, the total holding and indirect holding in Nokian Tyres shares owned by BlackRock, Inc. and its funds fell below the level of 5% of the share capital in Nokian Tyres plc, as a result of share transactions concluded on September 14, 2021. Total positions of BlackRock, Inc. and its funds subject to the notification: +-----

There are no items matching the current filter
There are no more items matching the current filter
Back to top